Pharmaceutical semi-solid composition of isotretinoin

Details Pharmaceutical semi-solid composition of isotretinoin Pharmaceutical semi-solid composition of isotretinoin

2001-09-21

2008-10-14

Hartley, Michael G. (Department: 1618)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Food or edible as carrier for pharmaceutical

C424S472000, C424S484000

Reexamination Certificate

active

07435427

ABSTRACT:
An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle.

REFERENCES:
patent: 4464394 (1984-08-01), Bollag
patent: 5252604 (1993-10-01), Nagy et al.
patent: 5993858 (1999-11-01), Crison et al.
patent: 6020003 (2000-02-01), Stroh et al.
patent: 6248363 (2001-06-01), Patel et al.
patent: 6267985 (2001-07-01), Chen et al.
patent: 6294192 (2001-09-01), Patel et al.
patent: 6383471 (2002-05-01), Chen et al.
patent: 6923988 (2005-08-01), Patel et al.
patent: A-0 184942 (1986-06-01), None
patent: WO 0025772 (2000-05-01), None
Koga K, Kawashima S, Murakami M. In vitro and in situ evidence for the contribution of Labrasol and Gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine. Eur J Pharm Biopharm. Nov. 2002; 54(3): 311-8 (see abstract).
PCT International Preliminary Examination Report.

Affiliated with

Also associated with

Rating

Pharmaceutical semi-solid composition of isotretinoin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical semi-solid composition of isotretinoin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical semi-solid composition of isotretinoin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4010385